Team/Members of the group:

• Dr Prerna Tewari, Senior Research Fellow
• Dr Ola Ibrahim, Post doctoral Research Fellow
• Dr David Joyce, Post doctoral Research Fellow
• Dr Mark Bates, Post doctoral Research Fellow
• Dr Colm Kerr, PhD candidate
• Ms Padma Naik, PhD candidate
• Dr Roisin O’Connor, MD candidate
• Dr Christine White, Visiting Researcher 

Close collaborators:
The National Screening Services, The Coombe Women and Infants University Hospital, Tallaght University Hospital, The National Maternity Hospital, The Rotunda Hospital,
Prof Linda Sharp, Newcastle University, UK, Dr Mairead O’Connor, University College Cork, Dr Kate Cushieri, University of Edinburgh, Prof Colm Bergin, Department of Genitourinary Medicine St James's Hospital, Prof Fiona Lyng (TUDublin) 

Main Funders: 
Health Research Board, Enterprise Ireland, Industry Partners 

Active research programmes:
Our CERVIVA consortium (www.cerviva.ie) led by Prof. O’Leary and  Prof. Martin at Trinity College Dublin, consists of a series of health research programmes focused on early detection and prevention of cervical cancer and pre-cancer and other HPV-related diseases. Our groups research programmes span basic science to translational research, across a broad spectrum of areas from molecular diagnostics, molecular epidemiology, health psychology, disease modelling and health economics. The overarching theme of these research programmes is to deliver the necessary evidence to inform clinical practice and policy to improve individual patient care in relation to cervical screening and other HPV-associated cancers, both in Ireland and internationally. Our group have held several inter-linked project and programme grants from the HRB and other national/international funders, which address different, but complementary, patient-focused and policy-related research questions relating to cervical and other HPV-associated cancers. 
CERVIVA is trans-sectoral, with close links to clinicians, service providers, industry partners and patient support organisations. Active stakeholder engagement is a key ethos and ensures that the research conducted addresses key questions and challenges encountered by stakeholders that can be translated into practice. A key objective for our group is to build capacity and expertise in the areas of cancer screening/disease prevention to address specific significant challenges for patients, policy-makers, service-providers and health professionals in cancer prevention and management.